Inhalation Sciences announces outcome of the rights issue
Inhalation Sciences Sweden AB (publ) (“ISAB” or the ”Company”) today announces the outcome of the rights issue of shares that the Company announced on April 6, 2023 (the “Rights Issue”). The Rights Issue has been subscribed for a total of approximately 23.0 percent, of which approximately 14.2 percent was subscribed for with the support of subscription rights and approximately 8.8 percent was subscribed for without the support of subscription rights. Approximately 57.0 percent was subscribed by underwriters. Through the Rights Issue, the Company receives approximately MSEK 13.7 before